新生儿病症和产后生长失速的关联 在早产新生儿中
Justyna Rogulska1,2, Tanis R Fenton3,4, Tomasz Szczapa1
1II Department of Neonatology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Healthcare (Basel, Switzerland)
|February 13, 2025
概括
在早产婴儿中,产后生长迟缓 (PGF) 与严重的健康问题,如脑损伤和肺部疾病有关. 早期发现PGF对于可以改善神经发育结果的干预措施至关重要.
科学领域:
- 新生儿科学 新生儿科学
- 儿科生长与发展 儿科生长与发展
- 神经发育儿科 神经发育儿科
背景情况:
- 在非常早产的新生儿中,产后生长迟缓 (PGF) 是不良神经发育结果的重要危险因素.
- 了解与PGF相关的具体因素对于及时干预至关重要.
研究的目的:
- 为了确定基线特征,产前风险因素和新生儿患病率与PGF的两个定义相关:严重的PGF (体重损失>2个z-score) 和复杂的PGF (体重损失>1,长度和头周长z-score).
主要方法:
- 对146名早产新生儿 (<32周妊娠年龄,<1500克) 的回顾性研究.
- 从临床电子数据库中提取的数据,包括人体测量和围产/新生儿发病率.
- 用Fenton 2013年早产生长图来诊断PGF计算的z-score的变化.
主要成果:
- 严重的PGF发生率为11%,复杂的PGF发生率为24%.
- 这两种PGF类型都与支气管肺功能失调症,早产严重视网膜病变,更长的呼吸支和更长的住院时间有关.
- 严重的PGF与手术性死性肠球炎有关;复杂的PGF与严重的脑损伤有关.
结论:
- 严重的和复杂的PGF都与显著的新生儿发病率有关,这可能解释了与低于最佳神经发育的联系.
- 早期识别失速生长可能会指导医疗和营养干预措施,以改善非常早产新生儿的结果.
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Nature and Nurture
20.3K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.3K
Inborn Errors of Metabolism
124
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
124


